Trexquant Investment LP Denali Therapeutics Inc. Transaction History

Trexquant Investment LP

$8.35 Billion
Q2 2025

A detailed history of Trexquant Investment LP transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 109,242 shares of DNLI stock, worth $1.88 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

109,242

Previous 113,224 3.52%

Holding current value

$1.88 Million

Previous $1.54 Million 0.71%

% of portfolio

0.02%

Previous 0.02%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$11.47 - $16.65 $45,673 - $66,300	-3,982 Reduced 3.52%	109,242 $1.53 Million
Q1 2025 May 14, 2025	BUY	$13.6 - $23.59 $714,924 - $1.24 Million	52,568 Added 86.67%	113,224 $1.54 Million
Q4 2024 Feb 12, 2025	BUY	$20.24 - $31.58 $731,109 - $1.14 Million	36,122 Added 147.23%	60,656 $1.24 Million
Q3 2024 Nov 12, 2024	BUY	$20.96 - $31.05 $514,232 - $761,780	24,534 New	24,534 $714,000
Q3 2023 Nov 13, 2023	SELL	$20.63 - $30.17 $507,209 - $741,759	-24,586 Reduced 36.73%	42,349 $873,000
Q2 2023 Aug 11, 2023	SELL	$23.37 - $32.96 $317,574 - $447,893	-13,589 Reduced 16.88%	66,935 $1.98 Million
Q1 2023 May 15, 2023	BUY	$21.91 - $32.67 $1.26 Million - $1.88 Million	57,669 Added 252.33%	80,524 $1.86 Million
Q4 2022 Feb 13, 2023	SELL	$26.28 - $33.92 $72,900 - $94,094	-2,774 Reduced 10.82%	22,855 $635,000
Q3 2022 Nov 14, 2022	BUY	$25.97 - $38.53 $665,585 - $987,485	25,629 New	25,629 $787,000
Q2 2021 Aug 12, 2021	SELL	$50.3 - $78.44 $814,457 - $1.27 Million	-16,192 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$53.8 - $81.53 $871,129 - $1.32 Million	16,192 New	16,192 $925,000
Q4 2020 Feb 11, 2021	SELL	$36.89 - $93.56 $1.48 Million - $3.74 Million	-40,025 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$23.13 - $38.84 $925,778 - $1.55 Million	40,025 New	40,025 $1.43 Million
Q3 2018 Nov 09, 2018	SELL	$12.46 - $21.74 $126,481 - $220,682	-10,151 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$15.25 - $21.02 $154,802 - $213,374	10,151 New	10,151 $155,000

Others Institutions Holding DNLI

# of Institutions

248

Shares Held

135M

Call Options Held

148K

Put Options Held

15.4K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.31B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account

Trexquant Investment LP Denali Therapeutics Inc. Transaction History